With the application of antiPD-L1-SPIOs@PLGA@Au, we enabled to target PD-L1, increase the accumulated concentration of nanoparticle in tumor and enhance B16F10 sensitivity to radiation. This evidence concerns the gene CD274 and neoplasm.